Nettsider med emneord «Immunotherapy»

Researchers have identified a novel immunotherapy for acute myeloid leukemia (AML). Immune cells are programmed to recognize a mutation found in leukemia patients. The results provide hope for new and effective treatment for the most common form of leukemia in adults.

Professor Johanna Olweus has been selected for the final of the Cancer Grand Challenges as part of a global research team. If successful, the team hopes to contribute in giving cancer patients new therapies.

Wednesday 21 June was the official opening of the new Centre of Excellence (CoE), PRIMA. The Centre's aim is to develop new and more effective immunotherapy that will improve cancer treatment and cure more patients.